发明名称 Use of GSTP1
摘要 The invention discloses the use of glutathione S-transferase Pb (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof.
申请公布号 US9375460(B2) 申请公布日期 2016.06.28
申请号 US201414275923 申请日期 2014.05.13
申请人 Medizinische Universitaet Wien 发明人 Aharinejad Seyedhossein
分类号 C12Q1/68;A61K38/45 主分类号 C12Q1/68
代理机构 Agris & von Natzmer LLP 代理人 von Natzmer Joyce;Agris & von Natzmer LLP
主权项 1. A method for treating a human individual at risk of developing cardiomyopathy (CMP) or ischemic heart disease (IHD) comprising: administering to said human individual glutathione S-transferase P1 (GSTP1) in an amount effective to reduce the risk of CMP and/or IHD, wherein the human individual is: a patient that has been diagnosed with myocarditis or hypertension, a patient that has suffered a myocardial infarction, a patient that has been diagnosed with angina pectoris, a patient with heart insufficiency or heart failure, and/or a patient that suffers from a failing myocardium.
地址 Vienna AT